Biogen Idec (NQ: BIIB )
205.00
+1.68
(+0.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Biogen Idec![]() ![]() ![]() ![]() ![]() ![]() ![]() From Biogen Inc.
Via GlobeNewswire
![]() ![]() ![]()
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®
September 29, 2023
From Biogen Inc.
Via GlobeNewswire
![]()
Biogen Completes Acquisition of Reata Pharmaceuticals
September 26, 2023
From Biogen Inc.
Via GlobeNewswire
![]()
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![]() ![]()
Biogen Appoints Jane Grogan as Head of Research
September 06, 2023
From Biogen Inc.
Via GlobeNewswire
![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]() ![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|